| 0 (0%) | 09-27 14:45 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 274.48 |
1-year : | 320.59 |
| Resists | First : | 235 |
Second : | 274.48 |
| Pivot price | 225.15 |
|||
| Supports | First : | 197.75 |
Second : | 174.74 |
| MAs | MA(5) : | 224.11 |
MA(20) : | 223.63 |
| MA(100) : | 206.89 |
MA(250) : | 181.35 |
|
| MACD | MACD : | 7 |
Signal : | 7.9  |
| %K %D | K(14,3) : | 58.7 |
D(3) : | 47.2 |
| RSI | RSI(14): 69 |
|||
| 52-week | High : | 248.16 | Low : | 126.96 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ BGNE ] has closed above the upper band by 0.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 68.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 235.02 - 235.84 | 235.84 - 236.59 |
| Low: | 225.55 - 226.6 | 226.6 - 227.56 |
| Close: | 229.2 - 230.66 | 230.66 - 232 |
Mon, 23 Dec 2024
BeiGene (BGNE) to Change Nasdaq Ticker Symbol to “ONC” - StreetInsider
Tue, 17 Dec 2024
BeiGene, Ltd.'s (NASDAQ:BGNE) recent 15% pullback adds to one-year year losses, institutional owners may take drastic measures - simplywall.st
Mon, 02 Dec 2024
Why Is BeiGene, Ltd. (BGNE) Among the Best High Growth Healthcare Stocks to Invest In Now? - Yahoo Finance
Tue, 26 Nov 2024
BeiGene to Present at Major Healthcare Conferences, Announces Rebrand to BeOne Medicines - Stock Titan
Fri, 15 Nov 2024
BeiGene, Ltd. (BGNE): Among 12 High Growth Large Cap Stocks to Buy Now - Yahoo Finance
Wed, 13 Nov 2024
Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 98 (M) |
| Shares Float | 749 (M) |
| Held by Insiders | 19.4 (%) |
| Held by Institutions | 46.9 (%) |
| Shares Short | 1,380 (K) |
| Shares Short P.Month | 999 (K) |
| EPS | -8.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 226.72 |
| Profit Margin | -25.5 % |
| Operating Margin | -13.9 % |
| Return on Assets (ttm) | -9.6 % |
| Return on Equity (ttm) | -23.3 % |
| Qtrly Rev. Growth | 39.5 % |
| Gross Profit (p.s.) | 201.37 |
| Sales Per Share | 240.68 |
| EBITDA (p.s.) | -57.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4,560 (M) |
| Levered Free Cash Flow | -5,260 (M) |
| PE Ratio | -28.19 |
| PEG Ratio | 0 |
| Price to Book value | 1.01 |
| Price to Sales | 0.95 |
| Price to Cash Flow | -4.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|